Gilead and Kite Oncology are creating the future of oncology. From antibody-drug conjugates and small molecules to cell therapy-based approaches, our R&D programs and partnerships are creating possibilities for people with overlooked, underserved and difficult -to-treat cancers. We are focused on helping to bring more life to people with cancer and changing the way cancer is treated.
Gilead and Kite Oncology are creating the future of oncology to help bring more life to people with cancer. At Gilead, we are focused on delivering transformational science, maximizing speed to the patient, and being a partner of choice. As the cell therapy leader, Kite’s singular focus is to treat and potentially cure cancer by harnessing the power of a patient’s own immune system. Together, Gilead and Kite Oncology provide hope for many types of tumors where there remains high unmet need.